ONCOLOGY

We cover the Onkologiapäivät 2023 and will give you the latest news within oncology I 2023

Go to page

News from oncology

Triplets frontline therapy increases PFS for patients with previously untreated advanced renal-cell carcinoma

Kidney cancer

Play the Video
8:54

September 2023 / Laurence Albiges

Don’t miss out on the latest news and findings within the field of oncology

Update your profile

We’ve split our coverage of oncology and hematology into two dedicated subsites.
Update your profile – with the specialty you’re interested in.

Go to profile

Read the latest magazine

Oncology / Hematology • No. 14 • 2023

Breast Cancer: The Future of HER2-Low Treatment
Lung Cancer: Pretreatment Platelet Count a Prognostic Marker
Multiple Myeloma: Belamaf and Dexamethasone – Safe, Effective Treatment
CLL: Small-Molecule Inhibitor Sequencing and Combination Therapies

Get access

Latest MEDtalks from oncology

Can we predict bladder cancer using the HUNT model?

August 2023 / Oncology / Oluf Dimitri Røe

Circulating methylated-HOXA9 tumor DNA as a biomarker in recurrent breast cancer

August 2023 / Oncology / Stine Bakkensen Bruun

Therapeutic options for patients with primary refractory or early relapsed DLBCL

June 2023 / Oncology / Manali Kamdar

Onkologiapäivät

We cover the Onkologiapäivät 2023 and will give you the latest news within oncology I 7.-8. September 2023

Go to Onkologiapäivät

Belamaf and Dexamethasone – Safe, Effective Multiple Myeloma Treatment

July 2023 / Hematology / Evangelos Terpos / Jan Andreasen

Belamaf shows deeper, longer-lasting myeloma response

July 2023 / Hematology / Jan Andreasen

EHA 2023: Professor Pieter Van Vlierberghe Posthumously Decorated with David Grimwade Award

June 2023 / Hematology / BestPractice Nordic

Promising Results from EHA23: Gilteritinib as Posttransplant Maintenance Therapy for FLT3-ITD AML Patients

June 2023 / Hematology / BestPractice Nordic

Evolving Concepts in Chronic Lymphocytic Leukemia (CLL) – Optimizing Treatment Strategies and Patient Experience

June 2023 / Hematology / BestPractice Nordic

Se oversigt

EHA23 – Novel CAR Therapy for AML Shows Favorable Pre-Clinical Outcomes

CAR-T

AML

EHA23

June 2023 / BestPractice Nordic

Cookie	Duration	Description
_ga	2 years	This cookie is installed by Google Analytics. The cookie is used to calculate visitor, session, camapign data and keep track of site usage for the site's analytics report. The cookies store information anonymously and assigns a randoly generated number to identify unique visitors.
_gid	1 day	This cookie is installed by Google Analytics. The cookie is used to store information of how visitors use a website and helps in creating an analytics report of how the wbsite is doing. The data collected including the number visitors, the source where they have come from, and the pages viisted in an anonymous form.

We cover the Onkologiapäivät 2023 and will give you the latest news within oncology I 2023

News from oncology

Triplets frontline therapy increases PFS for patients with previously untreated advanced renal-cell carcinoma

Don’t miss out on the latest news and findings within the field of oncology

Adjuvant treatment with 3rd generation EGFR-TKI can increase progression-free survival

WCLC 2023 – NSCLC: New Data on Perioperative Immunotherapy Treatment

Symptom control in cancer patients: Exploring the benefits of olanzapine.

HER2-Low treatment – The future of this important biomarker

Trastuzumab and HER2 Targeted Cancer Treatment

Exceptional response of lorlatinib and cabozantinib combination in ROS1-rearranged NSCLC

Osimertinib for the treatment of EGFR-mutant NSCLC in the adjuvant setting

Unraveling the HER2-Low Breast Cancer Puzzle – Treatment Sequencing and Targeted Therapies

Update your profile

Read the latest magazine

Oncology / Hematology • No. 14 • 2023

Latest MEDtalks from oncology

Can we predict bladder cancer using the HUNT model?

Circulating methylated-HOXA9 tumor DNA as a biomarker in recurrent breast cancer

Advancements and Emerging Challenges in HER2-Low Treatment

Insights into Tumor Microenvironment Antigens and Immunomodulation

DESTINY-Breast03 study: trastuzumab deruxtecan versus trastuzumab emtansine

Neoadjuvant chemotherapy for locally advanced colon cancer does not change OS

Therapeutic options for patients with primary refractory or early relapsed DLBCL

Onkologiapäivät

Belamaf and Dexamethasone – Safe, Effective Multiple Myeloma Treatment

Belamaf shows deeper, longer-lasting myeloma response

EHA 2023: Professor Pieter Van Vlierberghe Posthumously Decorated with David Grimwade Award

Promising Results from EHA23: Gilteritinib as Posttransplant Maintenance Therapy for FLT3-ITD AML Patients

Evolving Concepts in Chronic Lymphocytic Leukemia (CLL) – Optimizing Treatment Strategies and Patient Experience

EHA23 – Novel CAR Therapy for AML Shows Favorable Pre-Clinical Outcomes

Name & work area

We cover the Onkologiapäivät 2023 and will give you the latest news within oncology I 2023

News from oncology

Don’t miss out on the latest news and findings within the field of oncology

Stay updated on WCLC 2023

Adjuvant treatment with 3rd generation EGFR-TKI can increase progression-free survival

WCLC 2023 – NSCLC: New Data on Perioperative Immunotherapy Treatment

We participated on Onkologiapäivät 2023

Latest articles and MEDtalks from oncology

Symptom control in cancer patients: Exploring the benefits of olanzapine.

HER2-Low treatment – The future of this important biomarker

Trastuzumab and HER2 Targeted Cancer Treatment

Exceptional response of lorlatinib and cabozantinib combination in ROS1-rearranged NSCLC

Osimertinib for the treatment of EGFR-mutant NSCLC in the adjuvant setting

Unraveling the HER2-Low Breast Cancer Puzzle – Treatment Sequencing and Targeted Therapies

Update your profile

Read the latest magazine

Oncology / Hematology • No. 14 • 2023

Latest MEDtalks from oncology

Can we predict bladder cancer using the HUNT model?

Circulating methylated-HOXA9 tumor DNA as a biomarker in recurrent breast cancer

Advancements and Emerging Challenges in HER2-Low Treatment

Insights into Tumor Microenvironment Antigens and Immunomodulation

DESTINY-Breast03 study: trastuzumab deruxtecan versus trastuzumab emtansine

Neoadjuvant chemotherapy for locally advanced colon cancer does not change OS

Therapeutic options for patients with primary refractory or early relapsed DLBCL

Onkologiapäivät

Belamaf and Dexamethasone – Safe, Effective Multiple Myeloma Treatment

Belamaf shows deeper, longer-lasting myeloma response

EHA 2023: Professor Pieter Van Vlierberghe Posthumously Decorated with David Grimwade Award

Promising Results from EHA23: Gilteritinib as Posttransplant Maintenance Therapy for FLT3-ITD AML Patients

Evolving Concepts in Chronic Lymphocytic Leukemia (CLL) – Optimizing Treatment Strategies and Patient Experience

We cover

ASCO | Congress Site

ASCO GI | Congress site

ASCO GU | Congress Site

We cover

ESMO | Congress Site

SABCS | Congress Site

More from oncology